Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
about
Drug-eluting stents versus bare metal stents for angina or acute coronary syndromesDrug-eluting stents versus bare metal stents for angina or acute coronary syndromesEverolimus-eluting stents in interventional cardiologyAre Everolimus-Eluting Stents Associated With Better Clinical Outcomes Compared to Other Drug-Eluting Stents in Patients With Type 2 Diabetes Mellitus?: A Systematic Review and Meta-AnalysisDrug-eluting stents and acute myocardial infarction: A lethal combination or friends?Optical coherence tomography: from research to practiceThe Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical EvidenceDrug-Eluting Stents versus Bare-Metal Stents in Taiwanese Patients with Acute Coronary Syndrome: An Outcome Report of a Multicenter RegistryRETRACTED: Drug-eluting stents for acute coronary syndrome: a meta-analysis of randomized controlled trialsSurface Modification of Biodegradable Polymers towards Better Biocompatibility and Lower ThrombogenicityComparing the Clinical Outcomes between Drug Eluting Stents and Bare Metal Stents in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 10 Randomized Controlled TrialsImpact of multiple complex plaques on short- and long-term clinical outcomes in patients presenting with ST-segment elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIBorderline trend towards long-term mortality benefit from drug eluting stents implantation in ST-elevation myocardial infarction patients in Poland-data from NRDES registry.Long-term outcomes of drug-eluting versus bare-metal stent for ST-elevation myocardial infarctionEfficacy and safety of drug-eluting stents in patients with acute ST-segment-elevation myocardial infarction: a meta-analysis of randomized controlled trialsEffectiveness of drug-eluting stents versus bare-metal stents in large coronary arteries in patients with acute myocardial infarction.Very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction: a 15-year single-center experienceTissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial.In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticlesPreliminary experience with drug-coated balloon angioplasty in primary percutaneous coronary intervention.Restoration of microcirculatory patency after myocardial infarction: results of current coronary interventional strategies and techniques.The Food and Drug Administration and pragmatic clinical trials of marketed medical products.Hemodynamics in Coronary Arterial Tree of Serial Stenoses.Chinese Herbal Medicines Might Improve the Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Results of a Decision-Analytic Markov Model.Coronary stent thrombosis: current insights into new drug-eluting stent designsFirst- Versus Second-Generation Drug-Eluting Stents in Acute Coronary Syndromes (Katowice-Zabrze Registry).Altered gene expression in T-cell receptor signalling in peripheral blood leucocytes in acute coronary syndrome predicts secondary coronary events.Recent Advances in the Treatment of ST-Segment Elevation Myocardial Infarction.Conservative pharmacotherapy vs. staged percutaneous coronary intervention for non-culprit vessels in patients with ST-segment elevation myocardial infarction.Long-term outcomes of intravascular ultrasound-guided implantation of bare metal stents versus drug-eluting stents in primary percutaneous coronary interventionThe prognostic importance of left ventricular function in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial.Effect of Stents Coated with Artemisinin or Dihydroartemisinin in a Porcine Coronary Restenosis Model.Long-term outcomes in patients undergoing percutaneous coronary intervention with drug-eluting stents.Benefits of and safety concerns associated with drug-eluting coronary stents.A novel PDGF receptor inhibitor-eluting stent attenuates in-stent neointima formation in a rabbit carotid model.Decision-making: stenting in acute myocardial infarction.Local drug delivery for treatment of coronary and peripheral artery disease.Drug-eluting stents during ST-segment elevation acute myocardial infarction: a critical analysis.Drug-eluting Stents in Acute Coronary Syndrome: Is There a Risk of Stent Thrombosis with Second-Generation Stents?Bare-metal stents versus drug-eluting stents for primary angioplasty: long-term outcome.
P2860
Q24186681-0C9BB268-2373-445F-A46B-E93E3B335EB1Q24235466-85CF1376-B122-404F-9DDE-DC096BA6C647Q24630321-AC60E3EC-1EDE-45BF-9276-6F7A29EB2163Q26750693-19BF9751-6DF8-4BE1-B2BE-4C1D1A0B30EAQ26865052-7A7E7783-CF22-44E2-9F36-C8FCA4372019Q26991471-471211A3-BE9F-45D7-8411-A4CC9BC6E2F5Q28067509-A7FBF895-1316-4DD5-9754-ED0C2896F685Q28468707-556A8387-443F-4DC6-8C0F-B39129D883D1Q28536811-E7A3F432-9775-44A3-90DE-7B5310709FC3Q28551353-140412A2-52C7-423F-B10E-3A04B1A7D836Q28551554-A7E05050-9DD6-491D-8AB8-D172E1C4ADB7Q30398247-ED888797-9A3B-456B-AB82-6DC32C044BD4Q30667055-FC1DB6A5-8F66-491C-B58E-742E5CCE52D2Q33835973-78B8C9B8-F1A2-4F1A-AE4D-5246249F0DDAQ34190779-E3FABCE3-93C5-4C19-AD6E-2C1CC746BDC5Q34753360-08AB0D16-5745-4B56-84C9-C47C23063406Q35015411-6E247BC8-37A4-4A9A-AB80-C5C543FF4CB7Q35249476-F055DDE1-992D-4367-B684-98A1968C2F75Q35585791-C8A6D46B-4A0A-4D15-8A41-D84EC4BAA493Q35774068-97374020-6DA1-4C99-9C2B-17FCB4AB067EQ36011906-0F177EB8-C52D-4EB0-A5FF-6EB7E8CADE3DQ36117819-098E4F72-B112-4913-9BBE-D17D8E9F560FQ36148722-EB41C198-CC2D-4618-B052-03A5E64BFE29Q36163383-EF5D131C-99C1-46A5-A858-A914935A8D37Q36514842-E34D3F9B-B326-4C37-A706-8199243DDBB4Q37021327-5C33CCD9-B2B2-4FCB-866C-ED20D1127E6AQ37063521-B025AC08-1B81-48FC-8A56-1BF7D1612933Q37288480-3BBEBBFF-B834-4D2B-92B2-6C2947D4E892Q37582213-B2D3F611-6B0D-43DA-AD05-D6CFA3BECEEFQ37598827-D62DEA0D-9D47-4C73-A0AC-F6A16D451013Q37599599-180307D1-54D9-4C31-A623-5DC752ECC74DQ37619057-69F2625F-FA1C-440D-946A-4B7913195A4BQ37685137-21B5DE1F-E62F-4418-A87D-E2826300AA86Q37707419-6396CE95-1C8C-4A49-A4B6-02A22877B00EQ37707729-101CD377-B3CD-4634-BA26-EE658BF8F769Q37749818-A1C25B2D-3863-442E-A4C6-92AC67AFE652Q37765610-7FFB268A-7D03-47EC-BBDE-0A0195E18F22Q37871628-2DA38B86-B9A9-4FF6-B2C7-D9C2EA4C18CFQ37902075-9039CEA0-8C57-475B-ABAF-590D030797BAQ37906371-4F89F210-5085-4A92-A8C5-9F154B7FA1B3
P2860
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
@en
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
@nl
type
label
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
@en
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
@nl
prefLabel
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
@en
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
@nl
P2093
P50
P356
P1476
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.
@en
P2093
Alexandra J Lansky
Alison Kellock
Andrzej Ochala
Bernard J Gersh
Bruce R Brodie
Giulio Guagliumi
Gregg W Stone
HORIZONS-AMI Trial Investigators
Helen Parise
Jan Z Peruga
P304
P356
10.1056/NEJMOA0810116
P407
P577
2009-05-01T00:00:00Z